Scott Crampton, DPM
Podiatrist · Bullhead City, AZNPI 1508905373
Payments from drug & device makers
What this record shows
Treace Medical Concepts, Inc. accounts for 69.4% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $580, 4.2 times the $140 reported in 2019.
Across 16 payments — averaging $90.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Johnson & Johnson$178
- Integra Lifesciences Corporation$161
- Smith+Nephew$46
- Amgen$24
- Molnlycke Health Care US, LLC$21
- plus $13 from 1 others
What the payments were for
- Travel & lodging$74752%
- Food & beverage$69948%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 7 | $1,003 |
| Johnson & Johnson | 2 | $178 |
| Integra Lifesciences Corporation | 3 | $161 |
| Smith+Nephew | 1 | $46 |
| Amgen | 1 | $24 |
| Molnlycke Health Care US, LLC | 1 | $21 |
| Bioventus LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,446 in reported general payments places this provider in the 65th percentile of 151 podiatrist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 258 | $2,808 |
| Clotrimazole | 67 | $1,809 |
| Ammonium Lactate | 91 | $1,730 |
| Celecoxib | 39 | $1,200 |
| Terbinafine Hcl | 63 | $1,156 |
| Duloxetine Hcl | 76 | $1,038 |
| Doxycycline Hyclate | 88 | $969 |
| Ciclopirox | 37 | $925 |
| Methylprednisolone | 115 | $683 |
| Baclofen | 90 | $656 |
| Clindamycin Hcl | 58 | $579 |
| Mupirocin | 71 | $570 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 24 | $439 |
| Amitriptyline Hcl | 50 | $429 |
| Meloxicam | 147 | $300 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Bullhead City
- Kris DinucciScottsdale$1.4M
- Lewis FreedMesa$997K
- Stephen KominskySun City West$508K
- Chad WestphalPeoria$300K
- Kerry ZangMesa$111K
- Todd HaddonMesa$94K
- Paul BishopScottsdale$87K
- Barbara AungTucson$77K
- Mira PandyaScottsdale$21K
- Mark FormanScottsdale$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.